New England Biolabs Executive and Leadership Team

Salvatore Russello, the Chief Executive Officer at New England Biolabs, directs the overarching corporate strategy and long-term vision for the organization. This leadership role involves guiding the development of recombinant and native enzyme reagents to ensure alignment with the evolving needs of the global life science research community. By overseeing the integration of synthetic biology and next-generation sequencing solutions, the Chief Executive Officer maintains the company's competitive edge in the pharmaceutical manufacturing sector. Salvatore Russello fosters collaboration across all departments to drive operational excellence and scientific innovation. Through the management of high-level partnerships and the expansion of market reach, the Chief Executive Officer secures the company's position as a leader in genome editing support. This executive focus ensures that the organization remains dedicated to providing essential research tools while achieving sustainable growth and maintaining the highest standards of quality in the scientific marketplace.

Richard Ireland, the Chief Financial Officer at New England Biolabs, manages the fiscal health and capital allocation strategies for the organization. This role involves overseeing financial planning, reporting, and risk management to support the production of enzyme reagents and life science research tools. By analyzing market trends and operational costs, the Chief Financial Officer ensures that resources remain directed toward high-impact synthetic biology and genome editing projects. Richard Ireland collaborates with the executive team to optimize budgetary efficiency and drive long-term financial stability across all manufacturing operations. Through the implementation of robust financial controls, the Chief Financial Officer facilitates the scaling of global initiatives and supports the company's commitment to scientific advancement. This leadership position requires constant monitoring of economic variables to maintain the financial integrity of the organization while enabling the continued development of innovative reagents for the global research community.

Hiroshi Toshishige, the Neb Inc President & General Manager (Japan) at New England Biolabs, directs all commercial operations and market expansion initiatives within the Asian region. This role involves tailoring the distribution of recombinant and native enzyme reagents to meet the specific needs of the Japanese life science research market. By overseeing regional sales, marketing, and customer support, the Neb Inc President & General Manager (Japan) ensures that the company's genome editing and synthetic biology solutions reach key research institutions. Hiroshi Toshishige collaborates with the global executive team to align regional performance with the broader corporate strategy. Through the management of local partnerships and the optimization of supply chain logistics, the Neb Inc President & General Manager (Japan) drives significant growth in the regional pharmaceutical manufacturing sector. This leadership function requires deep market insight to maintain the company's competitive presence and ensure the successful delivery of research tools across the region.

Lennox Brown, the Chief Information Officer & Director, Information Technology at New England Biolabs, architects the digital infrastructure and data management systems essential for modern life science research. This role involves maintaining the integrity of critical research tools like REBASE, InBASE, and Polbase to ensure seamless access for the scientific community. By overseeing the deployment of advanced IT solutions, the Chief Information Officer & Director, Information Technology supports the company's manufacturing and sequencing workflows. Lennox Brown drives the digital transformation strategy to enhance operational efficiency and data security across all regional operations. Through the integration of sophisticated software platforms, the Chief Information Officer & Director, Information Technology enables the research team to accelerate discoveries in synthetic biology and genome editing. This leadership function ensures that the technological backbone of the organization remains scalable, secure, and fully aligned with the complex requirements of the pharmaceutical manufacturing industry.

Linda Stecchi, the Director, Human Resources at New England Biolabs, manages the talent acquisition, organizational development, and employee engagement strategies for the company. This role involves cultivating a high-performance culture that supports the production of specialized enzyme reagents and the advancement of life science research. By overseeing recruitment and professional development programs, the Director, Human Resources ensures that the organization attracts and retains top-tier scientific and operational talent. Linda Stecchi collaborates with leadership to align workforce capabilities with the company's mission in synthetic biology and next-generation sequencing. Through the implementation of comprehensive human capital policies, the Director, Human Resources fosters an environment conducive to innovation and excellence. This leadership position drives the organizational structure necessary to support global operations, ensuring that the workforce remains equipped to meet the rigorous demands of the pharmaceutical manufacturing sector while maintaining the company's core values.